Professional Documents
Culture Documents
Index
Up/Down
Last
DJ Industrials
13.07
0.07%
17,647
S&P 500
1.46
0.07%
2,041
Nasdaq
-17.54
0.37%
4,671
Russell 2000
-8.62
0.73%
1,168
Economic Data
New York Fed Empire Manufacturing for November rises to 10.16, below ests. of 12.0, but above
prior month of 6.17; Prices paid fell to 10.64 from 11.36, while New orders rose to 9.14 from 1.73 prior; Number of employees fell to 8.51 from 10.23 reading
Industrial production in the U.S. unexpectedly dropped in October, weighed down by declines at
utilities, mines and automakers, falling (-0.1%) after a 0.8% increase in September that was
smaller than previously estimated (and below est. for 0.2% increase)
Commodities
Oil prices end lower, but off worst levels, with WTI down -0.18 to $75.64 (lows of day $74.71),
while Brent dropped as low as $77.95 per barrel, also before paring losses (closed around $79 per
barrel). All eyes on OPEC meeting next week, where with prices at four-year lows, OPEC may be
forced to curb supply at its November meeting. Leading members of OPEC have previously
resisted calls to cut production as oil has fallen into a bear market
Gold prices ended a quiet session modestly lower after rallying sharply Friday (but still finished
the week lower), declining $2.10 to settle at $1,183.50 an ounce on a bounce in the dollar. Silver
prices posted biggest drop in more than a week
Nat gas prices rise, up more than 7% amid colder weather temperatures, rises 0.29 to 4.31 mln
Btu (near highs off lows of $4.113 mln btu)
Currencies/Treasuries
Today, the dollar index (DXY) approached a five-year high (back near the 88 level) as ECB
President Mario Draghi cited an urgent need to agree on concrete short-term commitments for
the euro area. The dollar rose and Treasuries fell on speculation the U.S. economy is robust
enough to withstand higher interest rates and a recession in Japan. The dollar traded up above
the 117 level against the yen before paring gains, while the euro declined
The yield on 10-year Treasuries added two bps to 2.34% in quiet trade. Federal Reserve
Governor Jerome Powell said he expects the U.S. central bank to raise interest rates next year,
adding the exact timing would depend on the pace of economic recovery
Macro
Up/Down
Last
WTI Crude
-0.18
75.64
Brent
-0.10
79.31
Gold
-2.10
1,183.50
EUR/USD
-0.0071
1.2455
JPY/USD
0.15
116.44
+0.014
2.336%
10-Year Note
Solar stocks weakness continued (group fell last week after softer revenue outlook from SPWR);
group also fell after better CSIQ earnings last week (group falling despite reports last week the
United States and China just agreed to a climate treaty, where U.S. agreed to reduce its carbon
emissions by 26% to 28% by 2025 (from 2005 levels) and China agreed to reach peak emissions
by 2030 shares of YGE, TSL, JASO have been falling) not SPWR spiked late day
Utility index bouncing (UTY), among best performers on the day, led by shares of CNP, SRE, EXC,
PCG, ED and NU to name a few winners
Financials
Master Trust data: Monthly Master Trust Credit Card data generally weaker: COF Oct Net Charge
offs (NCO) jumped to 3.16% from 2.79% in Sept as delinquencies rose to 3.31% ; JPM Oct NCOs
rise to 2.26% from 2.24% Mom (Oct. delinquencies also rise to 1.34%); ADS Oct NCOs jump 4.4%
from 3.6% (delinquencies dip); BAC NCOs 2.81% vs. 2.93% MoM; DFS Oct NCOs 2.1% vs. 2.2% in
Sept (but delinquencies rise to 1.8%); AXP NCOs rise to 1.3% from 1.2% in Sept
Stock movers; AON announces stock buyback; ALL downgraded at Keefe Bruyette; REIT sector
one of few outperformers early in financial sector (IYR)
Healthcare
M&A news in Healthcare/Pharma sector; AGN agreed to be acquired by ACT for $66B, getting
$219 per share http://goo.gl/FgDRUs (to repel hostile advance from VRX which said was willing
to pay up to $200 per share); PFE cut its year eps views after news it is teaming up w/ Germanys
Merck KGaA to develop new cancer license product (Merck KGaA to get $850M upfront
payment) http://goo.gl/nbzAt9
Hospital stocks rally; Bank America defended group saying threats to health-care reform
relatively low, with Obama likely to veto major changes to ACA, states likely to see work
around if Supreme court were to overturn subsidies (CYH, LPNT, HCA, UHS rise)
In stock news; FOLD reports positive phase III data on Cardiac/Composite endpoints from Fabry
study; INO ends 2013 prostate cancer agreement with Roche; KND files to sell 5M shares of
common stock; CLDX jumps as positive interim data from is Phase 2 clinical trial assessing the
safety and efficacy of rindopepimut in patients; ABBV says Phase 1 data show 33% response sate
in brain cancer; MRKs Vytorin reduced cholesterol ~20% more than statin alone and reduced
heart complications by 6.4% in long-awaited Improve-It study; REGN/SNY PCSK9 tops MRKs
Zetia in helping reduce LDL cholesterol; SNSS jumps after announcing late-breaking presentation
of phase III ALOR trial at ASH annual meeting
Industrials & Materials
Metals & Mining stocks; no specific news in metals, but seeing pullback in steel stocks (X), as well
as other industrial metals (AA, FCX, CLF); gold miners advanced throughout the day
Chemical stocks have been active plays given the recent pullback in oil prices, with shares of LYB,
WLK, DOW among names pulling back with price of oil
Transports little changed, but DJ Index still holding near all-time highs heading into holiday
season (more travel for airlines/more package delivery for UPS/FDX) lower energy prices
remain a tailwind for the sector
Want a free trial to The Hammerstone Report 4x Daily ? Sign-up for a trial today at www.
thehammerstonereport.com
***DISCLAIMER/LIMITATION OF LIABILITY: Hammerstone Inc. (the Report) provides information and data and does NOT provide any individual investment advice or money management
assistance and does NOT attempt to influence the sale or purchase of securities. The Report is intended for informational purposes only and does not claim to be actionable for investment
decisions. The information contained in the Report has been obtained from sources deemed to be reliable but is not represented to be complete, and it should not be relied upon as such. The
Report does not purport to be a complete analysis of any security, issuer, or industry and is not an offer or a solicitation of an offer to buy or sell any securities. The Report is prepared for
general information purposes only and does not consider the specific investment objectives, financial situation, and particular needs of any individual subscriber, person, or entity